natgillin/translations-raw huggingface dataset:
284  Polyarticular juvenile idiopathic arthritis (a type of juvenile arthritis that affects many joints) in patients from the age of 4 years who have had an inadequate response to (or are unable to take) methotrexate.
poliartikularnega juvenilnega idiopatskega artritisa (vrsta juvenilnega artritisa, ki prizadene številne sklepe) pri bolnikih od 4. leta starosti naprej, ki so se nezadostno odzvali na metotreksat (ali ga niso mogli jemati);
 Severe psoriasis in patients from the age of 8 years who have had an inadequate response to (or are unable to take), phototherapies or other systemic therapies.
269 • hude psoriaze pri bolnikih od 8. leta starosti naprej, ki so se nezadostno odzvali na fototerapije ali druge sistemske terapije (ali jih niso prenašali).
Your doctor may wish to monitor the treatment with Enbrel in case the infection worsens.  Blood disorders: Seek medical advice immediately if you or the child have any signs or symptoms such as persistent fever, sore throat, bruising, bleeding or paleness.
Mogoče bo zdravnik želel spremljati zdravljenje z zdravilom Enbrel za primer, če bi se okužba poslabšala. • Bolezni krvi:
285  Nervous system and eye disorders:
Ti simptomi namreč lahko kažejo na pojav smrtno nevarne bolezni krvi, pri kateri bo zdravljenje z zdravilom Enbrel morda treba prekiniti. • Bolezni živčevja in očesne bolezni:
If you feel that the effect of Enbrel is too strong or too weak, talk to your doctor or doctor or pharmacist.
Če menite, da je učinek zdravila Enbrel premočan ali prešibak, se posvetujte z zdravnikom ali s farmacevtom.
286 Alternatively, 50 mg may be given twice a week for up to 12 weeks, followed by 25 mg twice a week or 50 mg once a week.
Druga možnost je, da vam predpišejo 50 mg dvakrat na teden za največ 12 tednov, čemur sledi odmerek 25 mg dvakrat na teden ali 50 mg enkrat na teden.
Dosing for children and adolescents
271 Odmerjanje pri otrocih in mladostnikih
287 Other side effects that are not listed in this leaflet may occur.
Pojavijo se lahko tudi neželeni učinki, ki niso navedeni v tem navodilu.
 Trouble swallowing or breathing.  Swelling of the face, throat, hands, or feet.  Feeling nervous or anxious, throbbing sensations, sudden reddening of the skin and/ or a warm feeling.  Severe rash, itching, or hives (elevated patches of red or pale skin that often itch).
272 • Težave pri požiranju ali dihanju. • Otekanje obraza, žrela, rok ali nog. • Občutek živčnosti ali tesnobe, utripajoč občutek, nenadna pordelost kože in/ ali občutek toplote. • Hud izpuščaj, srbenje ali koprivnica (rdeče ali blede kožne spremembe nad ravnjo kože, ki pogosto srbijo).
288 various sites); localized swelling of the skin (angioedema); low blood platelet count; hives (elevated patches of red or pale skin that often itch); psoriasis; rash; inflammation or scarring of the lungs.
• Redki (pojavijo se lahko pri manj kot 1 od 1. 000 bolnikov): resne alergijske reakcije (vključno s hudim lokaliziranim otekanjem kože in piskajočim dihanjem), kombinacija znižanja števila trombocitov in rdečih ter belih krvnih celic, motnje živčevja (z znaki in simptomi, podobnimi multipli sklerozi ali vnetje očesnih živcev ali hrbtenjače), tuberkuloza, poslabšanje kongestivnega srčnega popuščanja, epileptični napadi, lupus ali lupusu podoben sindrom (med simptomi so lahko trdovraten izpuščaj, zvišana telesna temperatura, bolečine v sklepih in utrujenost), vnetje krvnih žil, nizko število rdečih krvnih celic, nizko število belih krvnih celic,
 Rare (may occur in less than 1 in 1,000 patients): serious allergic reactions (including severe localized swelling of the skin and wheezing); combined low platelet, red, and white blood cell count; nervous system disorders (with signs and symptoms similar to those of multiple sclerosis or inflammation of the nerves of the eyes or spinal cord); tuberculosis; worsening congestive heart failure; seizures; lupus or lupus-like syndrome (symptoms may include persistent rash, fever, joint pain, and tiredness); inflammation of the blood vessels; low red blood cell count, low white blood cell count, low neutrophil (a type of white blood cell) count; elevated liver blood tests; skin rash which may lead to severe blistering and peeling of the skin..
273 nizko število nevtrofilcev (vrste belih krvnih celic), povišane vrednosti jetrnih encimov pri krvnih preiskavah; kožni izpuščaj, ki lahko povzroči močno mehurjenje in luščenje kože.
Store in a refrigerator (2 – 8 C).
Shranjujte v hladilniku (2 °C – 8 °C).
Do not use if you notice the solution is not clear or contains particles.
Ne uporabljajte zdravila Enbrel, če opazite, da raztopina ni bistra ali vsebuje delce.
Medicines should not be disposed of via waster water or household waste.
Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
289 What Enbrel looks like and contents of the pack
Izgled zdravila Enbrel in vsebina pakiranja
Each pack contains 4, 8 or 24 single dose vials, 4, 8 or 24 pre-filled syringes of water for injections, 4, 8 or 24 needles, 4, 8 or 24 vial adaptors and 8, 16 or 48 alcohol swabs.
Vsako pakiranje vsebuje 4, 8 ali 24 enoodmernih vial, 4, 8 ali 24 napolnjenih injekcijskih brizg z vodo za injekcije, 4, 8 ali 24 igel, 4, 8 ali 24 adapterjev za viale in 8, 16 ali 48 alkoholnih tamponov.
For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.
274 Za vse morebitne nadaljnje informacije o tem zdravilu se lahko obrnite na predstavništvo imetnika dovoljenja za promet z zdravilom:
België/ Belgique/ Belgien Luxembourg/ Luxemburg Wyeth Pharmaceuticals S. A. / N. V.
Z o. o Wyeth Pharmaceuticals Luxembourg/ Luxemburg Tel: +48 22 457 1000 Tel: +353 1 449 3500 Wyeth Pharmaceuticals Fax: +48 22 457 1001 Fax: +353 1 449 3522 S. A. / N. V.
Ireland Wyeth Pharmaceuticals Tel: + 353 1 449 3500 Fax: + +353 1 449 3522
Portugal Ísland Česká Republika Wyeth Lederle Portugal (Farma) Lda.
Polska Wyeth Sp. z o. o Tel: +48 22 457 1000 Fax: + 48 22 457 1001
Icepharma hf.
Deutschland Wyeth Pharma GmbH Tel: + 49 180 2 29 93 84 Fax: +49 251 204 1128
Suomi/ Finland Kύπρος Deutschland Wyeth Wyeth Hellas (Cyprus Branch) Wyeth Pharma GmbH Puh/ Tel: +358 20 7414 870 AEBE Tel: +49 180 2 29 93 84 Fax: + 358 20 7414 879 Fax: +49 251 204 1128
България / Eesti/ Latvija/ Lietuva/ Österreich/ România/ Slovenija Wyeth-Lederle Pharma GmbH Tel/ Tãlr: +43 1 89 1140 Факс / Faks/ Fakss/ Faksas/ Fax: +43 1 89 114600
Sverige Magyarország България/ Eesti/ Latvija / Wyeth AB Wyeth Kft Lietuva/ Österreich/ România / Tel: +46 8 470 3200 Tel: +36 1 453 33 30 Slovenija Fax: +46 8 730 0666 Fax: +36 1 240 4632 Wyeth- Lederle Pharma GmbH Tel/ Tãlr: + 43 1 89 1140 Факс/ Faks/ Fakss/ Faksas/ faks: + 43 1 89 114600
Magyarország Wyeth Kft Tel: +36 1 453 33 30 Fax: +36 1 240 4632
Malta Ελλάδα
Sverige Wyeth AB Tel: + 46 8 470 3200 Fax: + 46 8 730 0666
United Kingdom
290 Ελλάδα Wyeth Hellas A. E. B. E.
Wyeth Hellas A. E. B. E.
United Kingdom Wyeth Pharmaceuticals Tel: + 44 845 367 0098 Fax: + 44 1628 414802
Wyeth Pharmaceuticals Tel: +44 845 367 0098 Fax: +44 1628 414802
Norge Wyeth Tlf: +47 40 00 23 40 Fax: +47 40 00 23 41
Norge France Wyeth Wyeth Pharmaceuticals France Tlf: +47 40 00 23 40 Tél: +33 1 41 02 70 00 Fax: +47 40 00 23 41 Fax: +33 1 41 02 70 10
Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http: / /www. emea. europa. eu
275 Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila (EMEA) http: // www. emea. europa. eu.
Choosing an injection site h.
Izbira mesta injiciranja h.
Preparing the injection site and injecting the Enbrel solution i.
Priprava mesta injiciranja in injiciranje raztopine zdravila Enbrel i.
Do not attempt to administer an injection until you are sure that you understand how to prepare and give the injection.
Dokler niste povsem prepričani, da razumete, kako je treba odmerek pripraviti in ga injicirati, si zdravila Enbrel ne poskušajte injicirati.
 Wash your hands thoroughly.  Select a clean well-lit, flat working surface.
• Temeljito si umijte roke. • Izberite čisto, dobro osvetljeno ravno delovno površino. • Podstavek z zdravilom mora vsebovati vse spodaj navedene pripomočke (če jih ne, ne uporabite zdravila in se posvetujte s farmacevtom).
291  The dose tray should contain the items listed below.
Vedno uporabljajte le naštete pripomočke.
DO NOT use any other syringe.
NE uporabljajte drugih injekcijskih brizg.
1 Enbrel vial 1 Pre-filled syringe containing clear, colourless solvent (water for injections) 1 Needle 1 Vial adaptor 2 Alcohol swabs  Inspect the expiry dates on both the vial label and the syringe label.
1 viala zdravila Enbrel 1 napolnjena injekcijska brizga z bistro, brezbarvno tekočino (vodo za injekcije) 1 igla 1 adapter za vialo 2 alkoholna tampona • Preverite rok uporabnosti na nalepki viale in brizge.
 Remove the contents of the tray  Remove the plastic cap from the Enbrel vial (see Diagram 1).
S podstavka vzemite vso vsebino. • Z viale zdravila Enbrel snemite plastičen pokrovček (glejte shemo 1).
Diagram 1.
Shema 1
 Use a new alcohol swab to clean the grey stopper on the Enbrel vial.
276 • Z drugim alkoholnim tamponom očistite siv gumijasti zamašek na viali.
After cleaning, do not touch the stopper with your hands or allow it to touch any surface.  Place the vial upright on a clean, flat surface.  Remove the paper backing from the vial adaptor package.  While still in the plastic package, place the vial adaptor on top of the Enbrel vial so that the vial adaptor spike is centered within the raised circle on top of the vial stopper (see Diagram 2).  Hold the vial firmly on the flat surface with one hand.
Po čiščenju se ga ne smete več dotikati z rokami ter pazite, da se z njim ne dotaknete drugih površin. • Vialo postavite pokonci, na ravno, čisto površino. • Odstranite papirnato ozadje embalaže, v kateri je adapter za viale. • Adapter viale pustite v plastični embalaži in ga položite na vialo zdravila Enbrel tako, da bo adapter viale poravnan z dvignjenim delom zamaška na viali (glejte shemo 2). • Na ravni površini primite vialo čvrsto z eno roko.
With the other hand, push STRAIGHT DOWN FIRMLY on the adaptor package until you feel the adaptor spike penetrate the vial stopper and FEEL AND HEAR THE ADAPTOR RIM LOCK INTO PLACE (see Diagram 3).
Adapterja NE POTISKAJTE pod kotom (glejte shemo 4).
DO NOT push down the adaptor at an angle (see Diagram 4).
Pomembno je, da adapter v celoti predre gumijasti zamašek viale.
CORRECT
PRAVILNO
INCORRECT
NEPRAVILNO
 While holding the vial in one hand, remove the plastic packaging from the vial adaptor (see Diagram 5).
• Z eno roko še vedno držite vialo, z drugo pa odstranite plastično embalažo iz adapterja (glejte shemo 5).
292 Diagram 5.
Shema 5
 Remove the protective cover from the syringe tip by breaking the white cap along the perforation.
• S konice injekcijske brizge odstranite zaščitni gumijasti pokrovček tako, da prelomite belo kapico na perforiranem delu.
This is done by holding the collar of the white cap while grasping the end of the white cap with the other hand and bending it down and then up until it is broken (see Diagram 6).
To naredite tako, da držite omot in z drugo roko sukate belo kapico gor ter dol, dokler se ne prelomi( glejte shemo 6).
DO NOT remove the white collar that remains on the syringe.
NE odstranjujte belega omota, ki ostane na brizgi.
Diagram 6.
Shema 6
 Do not use the syringe if this perforation is already broken.
• Če je zaščitni pokrovček že prelomljen na perforiranem delu, injekcijek brizge ne smete uporabiti.
Start again with another dose tray.  Holding the glass barrel of the syringe (not the white collar) in one hand, and the vial adaptor (not the vial) in the other, connect the syringe to the vial adaptor by inserting the tip into the opening and turn clockwise until completely secured (see Diagram 7).
V tem primeru vzemite novo embalažo zdravila Enbrel. • Z držanjem steklenega dela brizge (ne belega omota) v eni roki in adapterja viale (ne same viale) v drugi, brizgo spojite z adapterjem tako, da vstavite njeno konico v odprtino na adapterju in jo zavrtite v smeri urinega kazalca, dokler se ne ustavi (glejte shemo 7).
Diagram 7.
277 Shema 7
 While holding the vial upright on the flat surface, push the plunger VERY SLOWLY until all the solvent is in the vial.
• Medtem, ko držite vialo pokonci na ravni površini, potiskajte bat brizge ZELO POČASI, dokler ni ves vehikel v viali.
This will help to reduce foaming (lots of bubbles) (see Diagram 8).  Once the solvent is added to the Enbrel, the plunger may move up by itself.
Tako boste zmanjšali penjenje (nastajanje mehurčkov) (glejte shemo 8). • Ko je vehikel dodan zdravilu Enbrel, se lahko zgodi, da se bat brizge sam pomakne navzgor.
293 Diagram 8.
Shema 8
 With the syringe still attached, gently move the vial in circles a few times, to dissolve the powder (see Diagram 9).
• Medtem, ko je brizga še vedno v viali, nekajkrat nežno krožno zavrtite vialo, da se prašek raztopi (glejte shemo 9).
Do NOT use Enbrel if all the powder in the vial is not dissolved within 10 minutes.
NE uporabljajte zdravila Enbrel, če se ves prašek v viali ni raztopil v 10 minutah.
Start again with another dose tray.
V tem primeru si pripravite novo embalažo zdravila Enbrel.
Diagram 9.
Shema 9
 With the syringe still attached to the vial and vial adaptor, hold the vial upside down at eye level.
• Ko je brizga še vedno pritrjena na vialo in adapter, primite vialo obrnjeno na glavo, približno v višini oči.
Push the plunger all the way into the syringe (see Diagram 10).
Bat brizge potisnite do konca v brizgo (glejte shemo 10).
 Then, slowly pull the plunger back to draw the liquid into the syringe (see Diagram 11).
278 • Nato počasi potegnite bat nazaj, da posesa raztopino v brizgo (glejte shemo 11).
For adult patients, withdraw the entire volume.
Izvlecite celoten volumen raztopine.
After you have withdrawn the Enbrel from the vial, you may have some air in the syringe.
Po tem, ko ste potegnili Enbrel iz viale, je možno, da je v brizgo prišlo tudi nekaj zraka.
294 Diagram 11.
Shema 11
 With the vial held upside down, unscrew the syringe from the vial adaptor by turning it anti- clockwise (see Diagram 12).
• Vialo držite v smeri navzdol in odvijte brizgo iz adapterja tako, da jo zavrtite v nasprotno smer urinega kazalca (glejte shemo 12).
Diagram 12.
Shema 12
 Place the filled syringe on the clean, flat surface.
• Napolnjeno injekcijsko brizgo položite na čisto in ravno površino.
Placing the needle on the syringe
Namestitev igle na brizgo
 The needle has been placed in a plastic container to keep it sterile.  To open the plastic container, hold the short, wide end in one hand.
• Igla se nahaja v plastični embalaži, da lahko ostane sterilna. • Plastično embalažo odprete tako, da z eno roko primete za krajši, širši del.
Place your other hand on the longer portion of the container.  To break the seal, bend the larger end down and then up until broken (see Diagram 13).
Z drugo roko pa primete za daljši del embalaže. • Plombo prelomite tako, da upognete daljši del brizge navzdol in nato navzgor, dokler se ne prelomi (glejte shemo 13).
Diagram 13.
Shema 13
 Once the seal has been broken, remove the short, wide end of the plastic container.  The needle will remain in the long part of the package.  While holding the needle and container in one hand, pick up the syringe and insert the syringe tip into the needle opening.  Attach the syringe to the needle by turning it clockwise until completely secured (see Diagram 14).
• Po prelomu plombe, odstranite krajši, širši del plastične embalaže. • Igla bo ostala v daljšem delu embalaže. • Medtem, ko držite iglo z neodstranjenim delom embalaže v eni roki, primite z drugo roko brizgo ter vstavite konico brizge v odprtino igle. • Iglo pritrdite tako, da jo zavrtite v smer urinega kazalca, dokler se ne ustavi (glejte shemo 14).
295 Diagram 14.
279 Shema 14
 Remove the needle cover by firmly pulling it straight off the syringe taking care not to touch the needle or allow the needle to touch any surfaces (see Diagram 15).
• Z ravnim potegom odstranite pokrovček igle z injekcijske brizge in pri tem pazite, da se s prsti ne dotaknete igle in da se z iglo ne dotaknete ničesar (glejte shemo 15).
Diagram 15.
Shema 15
 While holding the syringe upright, remove any air bubbles by slowly pushing on the plunger until the air is removed (see Diagram 16).
• Brizgo obrnete navzgor in odstranite zrak iz nje tako, da počasi pritiskate na bat, dokler ni odstranjen ves zrak (glejte shemo 16).
Diagram 16.
Shema 16
 The three recommended injection sites for Enbrel include:
Za injiciranje zdravila Enbrel so priporočljiva tri injekcijska mesta:
(1) the front of the middle thighs; (2) the abdomen, except for the 5 cm area right around the navel; and (3) the outer area of the upper arms (see Diagram 17).
(1) na sredini sprednjega dela stegna; (2) na trebuhu, razen na področju 5 cm okrog popka; in (3) na zunanjem delu nadlakti (glejte shemo 17).
296 Diagram 17.
Shema 17.
DO NOT inject into areas where the skin is tender, bruised, red, or hard.
NE injicirajte v predelih, kjer je koža občutljiva,
Avoid areas with scars or stretch marks.
280 poškodovana, rdeča ali otrdela.
Avoid areas with scars or stretch marks.
Izogibajte se področij z brazgotinami in strijami.
(It may be helpful to keep notes on the location of the previous injections.)  If you or the child have psoriasis, you should try not to inject directly into any raised, thick, red, or scaly skin patches (“ psoriasis skin lesions”).
(Pomagalo bo, če si boste beležili mesta predhodnih injekcij.) • Če imate vi ali otrok luskavico, se morate izogibati neposrednemu injiciranju v vsa privzdignjena, zadebeljena, rdeča ali luskava področja na koži (‘ psoriatične kožne sprememebe ').
With the other hand, hold the syringe like a pencil.  With a quick, short motion, push the needle all the way into the skin at an angle between 45° and 90° (see Diagram 18).
Z drugo roko kot svinčnik držite brizgo. • S hitro in kratko kretnjo potisnite iglo do konca v kožo pod kotom 45 do 90 stopinj (glejte shemo 18).
Diagram 18.
Shema 18
Then push the plunger to inject all of the solution at a slow, steady rate (see Diagram 19).
Nato potisnite bar tako, da boste počasi in enakomerno injicirali vso raztopino (glejte shemo 19).
297 Diagram 19.
Shema 19
 When the syringe is empty, remove the needle from the skin; being careful to keep it at the same angle it was when it was inserted.  Press a cotton ball over the injection site for 10 seconds.
• Ko je brizga prazna, izvlecite iglo iz kože pod istim kotom, kot ste jo zabodli vanjo. • Na mesto injiciranja za 10 sekund pritisnite tampon iz vate.
 The syringe and needles should NEVER be re-used.
• Brizge in igel ne smete NIKOLI ponovno uporabiti.
Dispose of the needles and syringe as instructed by your doctor, nurse or pharmacist.
Uporabljene igle in brizge odstranjujte v skladu z navodili zdravnika, medicinske sestre ali farmacevta.
If you have any questions, please talk to a doctor, nurse or pharmacist who is familiar with Enbrel.
281 Če imate kakršnakoli vprašanja, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro, ki dobro poznajo zdravilo Enbrel.
INFORMATION FOR THE USER
282 NAVODILO ZA UPORABO
Enbrel 50 mg powder for solution for injection Etanercept
Enbrel 50 mg prašek za raztopino za injiciranje etanercept
You may need to read it again.  Your doctor will also give you a Patient Alert Card, which contains important safety information that you need to be aware of before and during treatment with Enbrel.  If you have any further questions, ask your doctor or pharmacist.  This medicine has been prescribed for you.
Morda ga boste želeli ponovno prebrati. • Zdravnik vam bo dal tudi opozorilno kartico bolnika, ki vsebuje pomembne varnostne podatke, ki jih morate poznati pred zdravljenjem z zdravilom Enbrel in med zdravljenjem. • Če imate dodatna vprašanja, se posvetujte z zdravnikom ali s farmacevtom. • Zdravilo je bilo predpisano vam osebno in ga ne smete dajati drugim.
It may harm them, even if their symptoms are the same as yours.  If you are concerned about any side effect, or if you notice any side effects that are not listed in this leaflet, please tell your doctor or pharmacist.
Njim bi lahko celo škodovalo, čeprav imajo znake bolezni, podobne vašim. • Če ste zaradi kateregakoli neželenega učinka zaskrbljeni ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Enbrel is also prescribed for the treatment of severe psoriasis in patients from the age of 8 years who have had an inadequate response to (or are unable to take) phototherapies or other systemic therapies.
Zdravilo Enbrel se predpisuje tudi za zdravljenje hude psoriaze pri bolnikih 8 leta starosti naprej, ki so se nezadostno odzvali na fototerapije ali druge sistemske terapije (ali jih niso prenašali).
299 Enbrel is not effective in the treatment of Wegener’ s granulomatosis, a rare inflammatory disease.
Zdravilo Enbrel ni učinkovito pri zdravljenju redke vnetne bolezni – Wegenerjeve granulomatoze.
If you have Wegener’ s granulomatosis talk to your doctor.
Če imate Wegenerjevo granulomatozo, se posvetujte s svojim zdravnikom.
2.
283 2.
If you are allergic to etanercept or any of the other ingredients of Enbrel.
Če se pojavi alergijska reakcija, npr. tiščanje ali piskanje v prsih, omotica ali izpuščaj, zdravila Enbrel ne smete več uporabljati (injicirati).
If you experience allergic reactions such as chest tightness, wheezing, dizziness or rash, do not inject more Enbrel, and contact your doctor immediately.  Serious blood infection:
Nemudoma se posvetujte s svojim zdravnikom. • Resna okužba krvi:
If you have or are at risk of developing a serious blood infection called sepsis.
Če imate resno okužbo krvi (sepso), ali če obstaja tveganje za njen pojav.
If you have an infection of any kind.
Če imate kakršnokoli okužbo.
If you develop a new infection, or are about to have any major surgery, your doctor may wish to monitor your treatment with Enbrel.  Infections/ diabetes:
Če se pojavi nova okužba, ali če imate predvideno kakršnakoli večjo operacijo, bo zdravnik morda želel zdravljenje z zdravilom Enbrel nadzirati. • Okužbe/ sladkorna bolezen:
Tell your doctor if you have a history of recurrent infections, or suffer from diabetes or other conditions that increase the risk of infection.  Infections/ monitoring:
Če imate ponavljajoče se okužbe, sladkorno bolezen ali kako drugo stanje, pri katerem je tveganje za okužbo večje, to povejte svojemu zdravniku. • Okužbe/ spremljanje:
Your doctor may decide to continue to monitor you for the presence of infections after you stop using Enbrel.  Tuberculosis:
Mogoče se bo vaš zdravnik odločil, da bo vas ali vašega otroka tudi po koncu zdravljenja spremljal glede prisotnosti okužb. • Tuberkuloza:
It is very important that you tell your doctor if you have ever had tuberculosis, or have been in close contact with someone who has had tuberculosis.
Zelo pomembno je, da poveste svojemu zdravniku, ali ste vi ali vaš otrok kdaj imeli tuberkulozo ali bili v tesnem stiku s kom, ki je imel tuberkulozo.
Your doctor may decide to test for the presence of hepatitis B infection before you begin treatment with Enbrel.  Hepatitis C:
Mogoče se bo vaš zdravnik odločil za test prisotnosti okužbe hepatitisa B, preden se boste vi ali vaš otrok začel( i) zdraviti z zdravilom Enbrel. • Hepatitis C:
Tell your doctor if you have hepatitis C.
Povejte zdravniku, če imate vi ali vaš otrok hepatitis C.
Seek medical advice immediately if you have any signs or symptoms such as persistent fever, sore throat, bruising, bleeding or paleness.
Če se pojavi katerikoli od naslednjih znakov ali simptomov, kot so trdovratna zvišana telesna temperatura, vnetje žrela, podplutbe na koži, krvavitve ali bledica, se nemudoma posvetujte s svojim zdravnikom.
Such symptoms may point to the existence of potentially life-threatening blood disorders, which may require discontinuation of Enbrel.  Nervous system and eye disorders:
Ti simptomi namreč lahko kažejo na pojav smrtno nevarne bolezni krvi, pri kateri bo zdravljenje z zdravilom Enbrel morda treba prekiniti. • Bolezni živčevja in očesne bolezni: